Vimarsana
Biggest News Aggregation in the World

Page 10 - Early Phase News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Early Phase. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Early Phase Today - Breaking & Trending Today

CenExel Creates Clinical Sciences Business Unit - Vimarsana News

CenExel Creates Clinical Sciences Business Unit

New Division Emphasizes Existing Focus on Scientific Expertise and Consulting...

NeoImmuneTech to Present First Data on NT-I7 (efineptakin alfa) in Combination with CAR-T tisagenlecleucel, at 2022 ASH Annual Meeting - Vimarsana News

NeoImmuneTech to Present First Data on NT-I7 (efineptakin alfa) in Combination with CAR-T tisagenlecleucel, at 2022 ASH Annual Meeting

/PRNewswire/ -- NeoImmuneTech, Inc. (NIT or "NeoImmuneTech"), a clinical-stage T cell-focused biopharmaceutical company, today announced it will present first...

Innate Pharma SA: Innate Pharma to Present Results From a Preliminary Analysis of the TELLOMAK Phase 2 Trial in Patients With Advanced Sezary Syndrome and ANKET Platform at ASH 2022 - Vimarsana News

Innate Pharma SA: Innate Pharma to Present Results From a Preliminary Analysis of the TELLOMAK Phase 2 Trial in Patients With Advanced Sezary Syndrome and ANKET Platform at ASH 2022

Innate will share preliminary results of the cohort evaluating lacutamab in Sezary syndrome patients post-mogamulizumab from the ongoing TELLOMAK Phase 2 trial Chief Scientific Officer, Eric

Gracell Biotechnologies to Present First Clinical Data of FasTCAR-T GC012F for Newly Diagnosed Multiple Myeloma at 64th American Society of Hematology Annual Meeting & Exposition - Vimarsana News

Gracell Biotechnologies to Present First Clinical Data of FasTCAR-T GC012F for Newly Diagnosed Multiple Myeloma at 64th American Society of Hematology Annual Meeting & Exposition

/PRNewswire/ -- Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to...

Investegate |Syncona Limited Announcements | Syncona Limited: Autolus to present clinical data updates at ASH - Vimarsana News

Investegate |Syncona Limited Announcements | Syncona Limited: Autolus to present clinical data updates at ASH

Investegate announcements from Syncona Limited, Autolus to present clinical data updates at ASH